Board Chair, FNIH; Venture Partner
Steven M. Paul, M.D. is the Founder and Chair of the Board at Seaport Therapeutics and a Venture Partner at Third Rock Ventures. He is also a Founder and Chairman of the Board at Rapport Therapeutics and Co-Founder and board member at Syremis Therapeutics. Dr. Paul is the former President and CEO of Karuna Therapeutics (now Bristol Myers Squibb), a biotechnology company developing medicines for schizophrenia, Alzheimer’s disease and pain. He is also a co-founder and former board member of Sage Therapeutics and Voyager Therapeutics. Dr. Paul was the Founding Director of the Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College, as well as professor of neuroscience, psychiatry and pharmacology. He is currently a professor of neurology and psychiatry at Washington University School of Medicine in St. Louis. Dr. Paul spent 17 years at Eli Lilly and Company, during which time he served in several key leadership roles, including Executive Vice President of Science and Technology and President of the Lilly Research Laboratories. Prior to Lilly, Dr. Paul served as a Laboratory/Branch Chief and the Scientific Director of the National Institute of Mental Health. He has also served as Medical Director in the Commissioned Corps of the United States Public Health Service. Dr. Paul has authored or co-authored more than 600 papers and book chapters. Dr. Paul is the chairman of the board of the Foundation for the National Institutes of Health. Dr. Paul received his bachelor’s degree in biology and psychology from Tulane University, and his M.S. and M.D. degrees from Tulane University School of Medicine.